時 間：2020年12月4日（周五）15:00
地 點(diǎn)：武漢大學(xué)櫻頂老圖書館
主講人：董晨教授 中國科學(xué)院院士
題 目：T細(xì)胞與自身免疫疾病
主講人簡介：
董晨教授1989年本科畢業(yè)于武漢大學(xué)，1996年獲美國阿拉巴馬大學(xué)伯明翰分校博士學(xué)位，1997至2000年在美國耶魯大學(xué)免疫學(xué)系從事博士后工作。曾任美國得克薩斯大學(xué)MD Anderson 癌癥中心免疫學(xué)系終身講席教授、炎癥與腫瘤中心主任。2013年回國工作，曾任清華大學(xué)醫(yī)學(xué)院院長，現(xiàn)任清華大學(xué)醫(yī)學(xué)院教授，清華大學(xué)免疫學(xué)研究所所長，上海交通大學(xué)醫(yī)學(xué)院教授，上海醫(yī)學(xué)前沿創(chuàng)新研究院（籌）PI。
董晨教授主要致力于免疫學(xué)研究，在T細(xì)胞分化和自身免疫疾病領(lǐng)域做出了多項開創(chuàng)性貢獻(xiàn)，其研究對于治療免疫性疾病帶來了深遠(yuǎn)的影響，也給腫瘤免疫治療提供新的思路。目前已發(fā)表論文200余篇，總被引用次數(shù)達(dá)28000余次，2014到2019年連續(xù)六年被評為全球“高被引科學(xué)家”。
董晨教授是美國科學(xué)促進(jìn)會會士、中國科學(xué)院院士、國家重點(diǎn)研發(fā)計劃“精準(zhǔn)醫(yī)學(xué)研究”項目負(fù)責(zé)人、基金委創(chuàng)新研究群體“炎癥生物學(xué)與疾病”項目負(fù)責(zé)人。曾獲得2009年美國免疫家學(xué)會BD Bioscience研究者獎、2019年國際細(xì)胞因子與干擾素協(xié)會Biolegend-William E.Paul Award獎?，F(xiàn)任Frontiers in Immunology?T Cell Biology主編，《中國科學(xué)?生命科學(xué)》副主編，Immunity、Cell Research等期刊的編委。
Dr. Dong is Professor and Director of the Institute for Immunology at Tsinghua University, Beijing, China. He is a member of the Chinese Academy of Sciences. Dr. Dong was Dean of the School of Medicine at Tsinghua University, and he also served as a Professor of Immunology and the Director of the Center for inflammation and Cancer at the University of Texas MD Anderson Cancer Center before his move to Tsinghua University.
Dr. Dong’s research is to understand the molecular mechanisms whereby immune and inflammatory responses are normally regulated, and to apply this knowledge to the understanding and treatment of autoimmunity and allergy disorders as well as cancer. The work from Dr. Dong’s group has led to the discoveries of Th17 and T follicular helper (Tfh) cell subsets in the immune system and elucidation of their biological and pathological functions.
Dr. Dong has over 200 publications and was rated highly cited researcher for six years from 2014 to 2019. The honors he has received include the 2009 American Association of Immunologists-BD Bioscience Investigator Award and 2019 International Cytokine and Interferon Society Biolegend-William E. Paul Award. He is a fellow of the American Association for the advancement of Science and a member of the Chinese Academy of Sciences. He is currently an Editor for Immunity, Editor-in-chief for Frontiers in Immunology-T Cell Biology and Associate Editor for China Sciences- Life Sciences.
